opipramol has been researched along with Anxiety Neuroses in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 15 (75.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (10.00) | 29.6817 |
2010's | 3 (15.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Connemann, BJ; Gahr, M; Hiemke, C | 1 |
Garg, K; Kar, SK | 1 |
Cubała, WJ; Jakuszkowiak-Wojten, K; Krupka-Matuszczyk, I; Krysta, K; Krzystanek, M; Murawiec, S; Warchala, A; Wiglusz, MS; Zawada, K | 1 |
Berger, W; Boerner, RJ; Kuhn, U; Mannel, M; Schmidt, U; Sommer, H | 1 |
BALLUS, C; MONTSERRAT, S; PASCUAL, B; PRAT, J; ROM, J | 1 |
ALVARADOFELIPE, J; GARCIATORRES, JA | 1 |
RETA, A | 1 |
LECLERC, C; VALDERRAMA, G | 1 |
DESTOUNES, G | 1 |
DOMENECHTORNER, FM; PIQUERSOLA, E; SERRAMERCADER, JM | 1 |
LISSANDRELLO, EC | 1 |
BOUCQUEY, JP; PIERLOOT, R | 1 |
IBEASMATA, F | 1 |
MOULINIER, B; PLAUCHU, M | 1 |
RASMUSSEN, R | 1 |
GROSSER, HH; RYAN, E | 1 |
Möller, HJ; Reimann, IW; Stoll, KD; Volz, HP | 1 |
Carney, MW; Maxwell, C | 1 |
Terzani, S | 1 |
Alapin, B; Sobieraj, R | 1 |
2 review(s) available for opipramol and Anxiety Neuroses
Article | Year |
---|---|
[Update Opipramol].
Topics: Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Drug Utilization; Germany; Humans; Opipramol; Somatoform Disorders | 2017 |
Modern indications for the use of opipramol.
Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Depressive Disorder; Drug Therapy, Combination; Humans; Opipramol; Somatoform Disorders | 2015 |
3 trial(s) available for opipramol and Anxiety Neuroses
Article | Year |
---|---|
Kava-Kava extract LI 150 is as effective as Opipramol and Buspirone in Generalised Anxiety Disorder--an 8-week randomized, double-blind multi-centre clinical trial in 129 out-patients.
Topics: Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Double-Blind Method; Drug Administration Schedule; Female; Germany; Humans; Kava; Male; Manifest Anxiety Scale; Middle Aged; Opipramol; Phytotherapy; Plant Extracts; Quality of Life; Sleep; Surveys and Questionnaires; Treatment Outcome | 2003 |
Opipramol for the treatment of generalized anxiety disorder: a placebo-controlled trial including an alprazolam-treated group.
Topics: Adolescent; Adult; Aged; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Female; Humans; Male; Middle Aged; Opipramol; Single-Blind Method; Treatment Outcome | 2001 |
Sequential double blind controlled trial of opipramol in anxiety neurosis.
Topics: Adult; Aged; Anxiety Disorders; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Opipramol; Placebos; Seizures; Sleep Wake Disorders | 1967 |
15 other study(ies) available for opipramol and Anxiety Neuroses
Article | Year |
---|---|
Mania, a probable adverse drug reaction of opipramol in a patient with generalized anxiety disorder.
Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Bipolar Disorder; Female; Humans; Middle Aged; Opipramol | 2015 |
[EXPERIENCES IN THE USE OF THE PREPARATION INSIDON (G 33040) IN PSYCHOSOMATIC MEDICINE].
Topics: Antidepressive Agents; Anxiety; Anxiety Disorders; Asthenia; Cardiovascular Diseases; Depression; Depressive Disorder, Major; Erectile Dysfunction; Fatigue; Gastroenterology; Humans; Hypochondriasis; Hysteria; Male; Mental Disorders; Neurotic Disorders; Opipramol; Psychosomatic Medicine; Psychotic Disorders; Respiratory Tract Diseases; Stuttering | 1963 |
[THERAPEUTIC TRIAL WITH A NEW PSYCHOTROPIC DRUG (G-33040)].
Topics: Antidepressive Agents; Anxiety; Anxiety Disorders; Depression; Depressive Disorder; Neurotic Disorders; Opipramol; Toxicology | 1963 |
[USE OF A NEW PSYCHOVEGETATIVE TRANQUILIZER IN GASTROENTEROLOGY].
Topics: Antidepressive Agents; Anxiety; Anxiety Disorders; Depression; Gastroenterology; Opipramol; Psychosomatic Medicine; Sleep Wake Disorders; Tranquilizing Agents | 1963 |
[AMBULATORY TREATMENT WITH A NEW DRUG G 33040 OR DINSIDON. RESULTS IN 126 CASES].
Topics: Anxiety; Anxiety Disorders; Neurotic Disorders; Opipramol; Sleep Initiation and Maintenance Disorders; Toxicology; Tranquilizing Agents | 1963 |
[AUTONOMIC SYNDROMES AND NEUROSES].
Topics: Antidepressive Agents; Anxiety; Anxiety Disorders; Autonomic Nervous System Diseases; Hydroxyzine; Hypothalamus; Meprobamate; Neurotic Disorders; Obsessive-Compulsive Disorder; Opipramol; Physiology; Syndrome | 1963 |
[CLINICAL EXPERIMENTATION WITH THE COMPOUND G 33040 (NISIDANA) IN INTERNAL MEDICINE].
Topics: Antidepressive Agents; Anxiety; Anxiety Disorders; Chemical Phenomena; Chemistry; Hyperthyroidism; Internal Medicine; Menopause; Neurotic Disorders; Obesity; Opipramol; Pharmacology; Toxicology | 1963 |
[THE CLINICIAN AND THE NEUROVEGETATIVE PROBLEMS].
Topics: Adolescent; Anxiety; Anxiety Disorders; Child; Erectile Dysfunction; Hearing Loss, Noise-Induced; Humans; Male; Neurotic Disorders; Opipramol; Psychology, Adolescent; Psychosomatic Medicine; Sleep Initiation and Maintenance Disorders; Tics; Toxicology; Tremor; Urination Disorders | 1963 |
[STUDY OF THE ACTION OF INSIDON (G-33040) IN 50 AMBULATORY PATIENTS WITH NEUROTIC AND FUNCTIONAL DISORDERS].
Topics: Antidepressive Agents; Antisocial Personality Disorder; Anxiety; Anxiety Disorders; Bipolar Disorder; Humans; Hysteria; Mental Disorders; Neurotic Disorders; Obsessive-Compulsive Disorder; Opipramol; Psychosomatic Medicine; Psychotic Disorders | 1963 |
[RESULTS OBTAINED WITH A PSYCHOVEGETATIVE HARMONIZER (G33040) IN PSYCHOSOMATIC MEDICINE. PRESENTATION AND CONCLUSIONS IN 30 CASES].
Topics: Antidepressive Agents; Anxiety; Anxiety Disorders; Depression; Neurotic Disorders; Obsessive-Compulsive Disorder; Opipramol; Psychosomatic Medicine; Statistics as Topic; Toxicology | 1963 |
[ON THE USE OF A DERIVATIVE OF THE DIBENZO-AZEPINE GROUP, G-33040, IN GENERAL MEDICINE].
Topics: Alcoholism; Antidepressive Agents; Anxiety; Anxiety Disorders; Azepines; Humans; Hyperthyroidism; Liver Cirrhosis; Neoplasms; Opipramol; Psychoses, Alcoholic; Psychotic Disorders; Tetany | 1963 |
[INSIDON TREATMENT IN MINOR PSYCHIC ILLNESSES. PRELIMINARY REPORT].
Topics: Antidepressive Agents; Anxiety; Anxiety Disorders; Bipolar Disorder; Depression; Humans; Mental Disorders; Neurotic Disorders; Opipramol; Psychotic Disorders | 1964 |
DRUG TREATMENT OF ANXIETY: A CONTROLLED STUDY OF OPIPRAMOL AND CHLORDIAZEPOXIDE.
Topics: Anxiety; Anxiety Disorders; Azepines; Biomedical Research; Chlordiazepoxide; Drug Therapy; Ethanol; Humans; Neurotic Disorders; Opipramol; Piperazines; Placebos | 1965 |
[Comparative evaluation of antidepressive-anxiolytic substances, with special references to Doxepin (Sinquan), a diphenylmethane derivative].
Topics: Adult; Age Factors; Antidepressive Agents; Anxiety Disorders; Bipolar Disorder; Depression; Depressive Disorder, Major; Dibenzoxepins; Female; Humans; Male; Middle Aged; Neurotic Disorders; Opipramol; Sex Factors | 1972 |
[Insidon in the treatment of pseudoneurotic reactions and neuroses with prevailing depressive and hypochondriac symptoms].
Topics: Adult; Aged; Anxiety Disorders; Depression; Female; Humans; Hypochondriasis; Hysteria; Male; Middle Aged; Neurotic Disorders; Opipramol | 1966 |